Antiandrogens: all 479 studies that test it
Page 3 of 5. Open to participants first (92), then studies with results posted, then the rest; newest registration first within each.
- Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate CancerCompletedNCT01547299Phase 2Results posted
- A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100CompletedNCT01534052Phase 2Results posted
- Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001CompletedNCT01429064Phase 2Results posted
- Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerActive, not recruitingNCT01368588Phase 3Results posted
- Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)CompletedNCT01360645Phase 3Results posted
- Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)CompletedNCT01360632Phase 3Results posted
- Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerActive, not recruitingNCT01342367Not applicableResults posted
- Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerCompletedNCT01317641Phase 1/2Results posted
- A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone TherapyCompletedNCT01302041Phase 2Results posted
- A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerCompletedNCT01288911Phase 2Results posted
- A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerCompletedNCT01212991Phase 3Results posted
- Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate CancerTerminatedNCT01200810Phase 2Results posted
- Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)CompletedNCT01171898Phase 1/2Results posted
- Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of EnzalutamideCompletedNCT01091103Phase 2Results posted
- Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex® 50 mg Tablet in Healthy Subjects Under Fed ConditionsCompletedNCT01044706Phase 1Results posted
- Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyCompletedNCT00974311Phase 3Results posted
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerCompletedNCT00936390Phase 3Results posted
- Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate CancerTerminatedNCT00924807Phase 1/2Results posted
- Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate CancerTerminatedNCT00918385Phase 2Results posted
- An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the ProstateCompletedNCT00913263Phase 1/2Results posted
- Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary SyndromeTerminatedNCT00729560Not applicableResults posted
- Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian CancerCompletedNCT00699907Phase 2Results posted
- Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric DisorderCompletedNCT00611923Phase 4Results posted
- Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's CycleCompletedNCT00586898Phase 2Results posted
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerActive, not recruitingNCT00567580Phase 3Results posted
- Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate CancerActive, not recruitingNCT00544830Phase 2Results posted
- A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate CancerCompletedNCT00510718Phase 1Results posted
- Bicalutamide in Treating Patients With Metastatic Breast CancerCompletedNCT00468715Phase 2Results posted
- Metabolic Syndrome in PCOS: Precursors and InterventionsCompletedNCT00442689Not applicableResults posted
- External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerTerminatedNCT00388804Phase 3Results posted
- Maximal Suppression of the Androgen Axis in Clinically Localized Prostate CancerCompletedNCT00298155Phase 2Results posted
- Effects of IAS in Men With Localized Biochemical Relapsed Prostate CancerCompletedNCT00223665Phase 2Results posted
- A Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00105196Phase 3Results posted
- Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]CompletedNCT00094328Phase 2Results posted
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00005044Phase 3Results posted
- Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for RecurrenceTerminatedNCT00003645Phase 3Results posted
- Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyCompletedNCT00002874Phase 3Results posted
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00002597Phase 3Results posted
- Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate CancerActive, not recruitingNCT06631521Phase 1
- COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerActive, not recruitingNCT06627530Phase 4
- Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.CompletedNCT06601205Phase 2/3
- A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade GliomaWithdrawnNCT06501911Phase 1
- Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)Active, not recruitingNCT06463457Phase 2
- A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer.WithdrawnNCT06018116Phase 2
- Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial TreatmentTerminatedNCT05999968Phase 1
- A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.CompletedNCT05938270Phase 1
- A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCActive, not recruitingNCT05884398Phase 3
- A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesActive, not recruitingNCT05794906Phase 3
- Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)CompletedNCT05694819Phase 2
- Androgen Receptor Signaling and Prostate-Specific Membrane Antigen ExpressionActive, not recruitingNCT05683964Early Phase 1
- Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland CancersActive, not recruitingNCT05669664Phase 2
- Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne VulgarisCompletedNCT05478330Not applicable
- Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate CancerActive, not recruitingNCT05367440Phase 1/2
- NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsTerminatedNCT05252390Phase 1
- Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate CancerStatus unknownNCT05212857Phase 2
- An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)Active, not recruitingNCT05112965Phase 3
- Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialActive, not recruitingNCT05050084Phase 3
- Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate CancerTerminatedNCT05037500Phase 1
- FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT05011188Phase 1/2
- HC-1119 Adjuvant Treatment for Hospitalized COVID-19 PatientsStatus unknownNCT04986176Phase 3
- Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate CancerActive, not recruitingNCT04943536Phase 1
- Psma Intensity Can be Altered by Androgen and Phospho-SrC ObstructionCompletedNCT04925648Phase 2
- The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of ProstateCompletedNCT04848181Early Phase 1
- The Effect of Polycystic Ovary Syndrome Treatment on MetabolomicsStatus unknownNCT04831151Not applicable
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCActive, not recruitingNCT04821622Phase 3
- Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerCompletedNCT04666129Phase 1
- Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.CompletedNCT04655365Phase 2
- Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)CompletedNCT04558866Phase 2
- A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate CancerActive, not recruitingNCT04557059Phase 3
- Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialActive, not recruitingNCT04513717Phase 3
- Bicalutamide to Block TMPRSS2 in Males With COVID-19 InfectionWithdrawnNCT04509999Phase 3
- Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE StudyActive, not recruitingNCT04484818Phase 3
- Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by BayerActive, not recruitingNCT04464226Phase 3
- Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1TerminatedNCT04456049Phase 2
- Oral EPI-7386 in Patients with Castration-Resistant Prostate CancerTerminatedNCT04421222Phase 1
- Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate CancerTerminatedNCT04409288Phase 3
- Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerCompletedNCT04381832Phase 1/2
- Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMAActive, not recruitingNCT04319783Phase 2
- Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical ProstatectomyActive, not recruitingNCT04295447Phase 2
- A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate CancerCompletedNCT04284761Phase 1
- Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate CancerActive, not recruitingNCT04267887Phase 2
- Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsStatus unknownNCT04248621Phase 4
- Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After ProstatectomyActive, not recruitingNCT04181203Phase 3
- A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic FunctionCompletedNCT04154774Phase 1
- Targeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic BCTerminatedNCT04142060Phase 2
- Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstateActive, not recruitingNCT04136353Phase 3
- Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialActive, not recruitingNCT04134260Phase 3
- A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate CancerCompletedNCT04094519Phase 1
- Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)Active, not recruitingNCT04070209Phase 2
- INTREPId (INTermediate Risk Erection PreservatIon Trial)Active, not recruitingNCT04025372Phase 2
- PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNAActive, not recruitingNCT04015622Phase 2
- A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.TerminatedNCT03971110Phase 4
- Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side EffectsCompletedNCT03927391Phase 4
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerActive, not recruitingNCT03902951Phase 2
- Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.TerminatedNCT03869762Phase 2
- HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)TerminatedNCT03850795Phase 3
- Combination of Entinostat and Enzalutamide in Advanced Prostate CancerTerminatedNCT03829930Phase 1
- Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate CancerActive, not recruitingNCT03821792Phase 2
- A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy ParticipantsCompletedNCT03802682Phase 1
- A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug SwitchCompletedNCT03778047Phase 1